{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:56:08Z","timestamp":1780970168446,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To address the escalating problem of antimicrobial resistance and the dwindling antimicrobial pipeline, we have developed a library of novel aerosolizable silver-based antimicrobials, particularly for the treatment of pulmonary infections. To rapidly screen this library and identify promising candidates, we have devised a novel <jats:italic>in vitro<\/jats:italic> metric, named the\u00a0\u201cdrug efficacy metric\u201d (DEM), which integrates both the antibacterial activity and the\u00a0on-target, host cell cytotoxicity. DEMs calculated using an on-target human bronchial epithelial cell-line correlates well (R<jats:sup>2<\/jats:sup>\u2009&gt;\u20090.99) with <jats:italic>in vivo<\/jats:italic> efficacy, as measured by median survival hours in a <jats:italic>Pseudomonas aeruginosa<\/jats:italic> pneumonia mouse model following aerosolized antimicrobial treatment. In contrast, DEMs derived using off-target primary human dermal fibroblasts correlate poorly (R<jats:sup>2<\/jats:sup>\u2009=\u20090.0595), which confirms our hypothesis. SCC1 and SCC22 have been identified as promising drug candidates through these studies, and SCC22 demonstrates a dose-dependent survival advantage compared to sham treatment. Finally, silver-bearing biodegradable nanoparticles were predicted to exhibit excellent <jats:italic>in vivo<\/jats:italic> efficacy based on its <jats:italic>in vitro<\/jats:italic> DEM value, which was confirmed in our mouse pneumonia model. Thus, the DEM successfully predicted the efficacy of various silver-based antimicrobials, and may serve as an excellent tool for the rapid screening of potential antimicrobial candidates without the need for extensive animal experimentation.<\/jats:p>","DOI":"10.1038\/s41598-018-24200-w","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T10:36:09Z","timestamp":1523961369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A novel in vitro metric predicts in vivo efficacy of inhaled silver-based antimicrobials in a murine Pseudomonas aeruginosa pneumonia model"],"prefix":"10.1038","volume":"8","author":[{"given":"Parth N.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kush N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasur A.","family":"Tagaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Torrealba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuwu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick O.","family":"Wagers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Panzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiley J.","family":"Youngs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Wooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"24200_CR1","unstructured":"Antibiotic resistance threats in the United States, 2013. (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, 2013)."},{"key":"24200_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","volume":"15","author":"JB Lyczak","year":"2002","unstructured":"Lyczak, J. B., Cannon, C. L. & Pier, G. B. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15, 194\u2013222 (2002).","journal-title":"Clin Microbiol Rev"},{"key":"24200_CR3","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","volume":"288","author":"A Oliver","year":"2000","unstructured":"Oliver, A., Canton, R., Campo, P., Baquero, F. & Blazquez, J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288, 1251\u20131254 (2000).","journal-title":"Science"},{"key":"24200_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1378\/chest.109.4.1019","volume":"109","author":"S Crouch Brewer","year":"1996","unstructured":"Crouch Brewer, S., Wunderink, R. G., Jones, C. B. & Leeper, K. V. Jr. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 109, 1019\u20131029 (1996).","journal-title":"Chest"},{"key":"24200_CR5","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/338782","volume":"34","author":"DM Livermore","year":"2002","unstructured":"Livermore, D. M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34, 634\u2013640 (2002).","journal-title":"Clin Infect Dis"},{"key":"24200_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/jac\/47.6.789","volume":"47","author":"CJ Henwood","year":"2001","unstructured":"Henwood, C. J., Livermore, D. M., James, D. & Warner, M. Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test. J Antimicrob Chemother 47, 789\u2013799 (2001).","journal-title":"J Antimicrob Chemother"},{"key":"24200_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3109\/10408449609012524","volume":"26","author":"MA Hollinger","year":"1996","unstructured":"Hollinger, M. A. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol 26, 255\u2013260 (1996).","journal-title":"Crit Rev Toxicol"},{"key":"24200_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/10408449309117116","volume":"23","author":"JJ Hostynek","year":"1993","unstructured":"Hostynek, J. J., Hinz, R. S., Lorence, C. R., Price, M. & Guy, R. H. Metals and the skin. Crit Rev Toxicol 23, 171\u2013235 (1993).","journal-title":"Crit Rev Toxicol"},{"key":"24200_CR9","first-page":"131","volume":"26","author":"HJ Klasen","year":"2000","unstructured":"Klasen, H. J. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 26, 131\u2013138 (2000).","journal-title":"Renewed interest for silver. Burns"},{"key":"24200_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0305-4179(99)00108-4","volume":"26","author":"HJ Klasen","year":"2000","unstructured":"Klasen, H. J. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 26, 117\u2013130 (2000).","journal-title":"Burns"},{"key":"24200_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0168-6445(03)00047-0","volume":"27","author":"S Silver","year":"2003","unstructured":"Silver, S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 27, 341\u2013353 (2003).","journal-title":"FEMS Microbiol Rev"},{"key":"24200_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/bmj.1.6161.446","volume":"1","author":"K Bridges","year":"1979","unstructured":"Bridges, K., Kidson, A., Lowbury, E. J. & Wilkins, M. D. Gentamicin- and silver-resistant Pseudomonas in a burns unit. Br Med J 1, 446\u2013449 (1979).","journal-title":"Br Med J"},{"key":"24200_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/5545","volume":"5","author":"A Gupta","year":"1999","unstructured":"Gupta, A., Matsui, K., Lo, J. F. & Silver, S. Molecular basis for resistance to silver cations in Salmonella. Nat Med 5, 183\u2013188 (1999).","journal-title":"Nat Med"},{"key":"24200_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0140-6736(75)91138-1","volume":"1","author":"GL McHugh","year":"1975","unstructured":"McHugh, G. L., Moellering, R. C., Hopkins, C. C. & Swartz, M. N. Salmonella typhimurium resistant to silver nitrate, chloramphenicol, and ampicillin. Lancet 1, 235\u2013240 (1975).","journal-title":"Lancet"},{"key":"24200_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0162-0134(90)80030-2","volume":"39","author":"ME Starodub","year":"1990","unstructured":"Starodub, M. E. & Trevors, J. T. Silver accumulation and resistance in Escherichia coli R1. J Inorg Biochem 39, 317\u2013325 (1990).","journal-title":"J Inorg Biochem"},{"key":"24200_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/BF01141173","volume":"3","author":"ME Starodub","year":"1990","unstructured":"Starodub, M. E. & Trevors, J. T. Mobilization of Escherichia coli R1 silver-resistance plasmid pJT1 by Tn5-Mob into Escherichia coli C600. Biol Met 3, 24\u201327 (1990).","journal-title":"Biol Met"},{"key":"24200_CR17","first-page":"48","volume":"103","author":"A Lansdown","year":"2007","unstructured":"Lansdown, A. & Williams, A. Bacterial resistance to silver-based antibiotics. Nurs Times 103, 48\u201349 (2007).","journal-title":"Nurs Times"},{"key":"24200_CR18","doi-asserted-by":"publisher","first-page":"6811","DOI":"10.1021\/jm060711t","volume":"49","author":"A Kascatan-Nebioglu","year":"2006","unstructured":"Kascatan-Nebioglu, A. et al. Synthesis from caffeine of a mixed N-heterocyclic carbene-silver acetate complex active against resistant respiratory pathogens. J Med Chem 49, 6811\u20136818 (2006).","journal-title":"J Med Chem"},{"key":"24200_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.ccr.2006.08.019","volume":"251","author":"A Kascatan-Nebioglu","year":"2007","unstructured":"Kascatan-Nebioglu, A., Panzner, M. J., Tessier, C. A., Cannon, C. L. & Youngs, W. J. N-Heterocyclic carbene\u2013silver complexes: A new class of antibiotics. Coord Chem Rev 251, 884\u2013895 (2007).","journal-title":"Coord Chem Rev"},{"key":"24200_CR20","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1021\/jm0708679","volume":"51","author":"KM Hindi","year":"2008","unstructured":"Hindi, K. M. et al. Synthesis, stability, and antimicrobial studies of electronically tuned silver acetate N-heterocyclic carbenes. J Med Chem 51, 1577\u20131583 (2008).","journal-title":"J Med Chem"},{"key":"24200_CR21","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1128\/AAC.00314-09","volume":"53","author":"CL Cannon","year":"2009","unstructured":"Cannon, C. L. et al. In vitro and murine efficacy and toxicity studies of nebulized SCC1, a methylated caffeine-silver(I) complex, for treatment of pulmonary infections. Antimicrob Agents Chemother 53, 3285\u20133293 (2009).","journal-title":"Antimicrob Agents Chemother"},{"key":"24200_CR22","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1021\/cr800500u","volume":"109","author":"KM Hindi","year":"2009","unstructured":"Hindi, K. M., Panzner, M. J., Tessier, C. A., Cannon, C. L. & Youngs, W. J. The medicinal applications of imidazolium carbene-metal complexes. Chem Rev 109, 3859\u20133884 (2009).","journal-title":"Chem Rev"},{"key":"24200_CR23","doi-asserted-by":"publisher","first-page":"7308","DOI":"10.1039\/b907726j","volume":"35","author":"MJ Panzner","year":"2009","unstructured":"Panzner, M. J. et al. A theobromine derived silver N-heterocyclic carbene: synthesis, characterization, and antimicrobial efficacy studies on cystic fibrosis relevant pathogens. Dalton Trans 35, 7308\u20137313 (2009).","journal-title":"Dalton Trans"},{"key":"24200_CR24","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1039\/c2dt00055e","volume":"41","author":"BD Wright","year":"2012","unstructured":"Wright, B. D. et al. Synthesis, characterization, and antimicrobial activity of silver carbene complexes derived from 4,5,6,7-tetrachlorobenzimidazole against antibiotic resistant bacteria. Dalton Trans 41, 6500\u20136506 (2012).","journal-title":"Dalton Trans"},{"key":"24200_CR25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/jac\/dkr408","volume":"67","author":"JG Leid","year":"2012","unstructured":"Leid, J. G. et al. In vitro antimicrobial studies of silver carbene complexes: activity of free and nanoparticle carbene formulations against clinical isolates of pathogenic bacteria. J Antimicrob Chemother 67, 138\u2013148 (2012).","journal-title":"J Antimicrob Chemother"},{"key":"24200_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ica.2010.08.008","volume":"364","author":"AR Knapp","year":"2010","unstructured":"Knapp, A. R. et al. Synthesis and antimicrobial studies of silver N-heterocyclic carbene complexes bearing a methyl benzoate substituent. Inorganica Chim Acta 364, 125\u2013131 (2010).","journal-title":"Inorganica Chim Acta"},{"key":"24200_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1513\/pats.200409-049TA","volume":"1","author":"JS Patton","year":"2004","unstructured":"Patton, J. S., Fishburn, C. S. & Weers, J. G. The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc 1, 338\u2013344 (2004).","journal-title":"Proc Am Thorac Soc"},{"key":"24200_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/jac\/dkn059","volume":"61","author":"P Meers","year":"2008","unstructured":"Meers, P. et al. Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother 61, 859\u2013868 (2008).","journal-title":"J Antimicrob Chemother"},{"key":"24200_CR29","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1016\/j.biomaterials.2009.03.044","volume":"30","author":"KM Hindi","year":"2009","unstructured":"Hindi, K. M. et al. The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies. Biomaterials 30, 3771\u20133779 (2009).","journal-title":"Biomaterials"},{"key":"24200_CR30","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1021\/nn400322f","volume":"7","author":"PN Shah","year":"2013","unstructured":"Shah, P. N. et al. Synthesis, characterization, and in vivo efficacy of shell cross-linked nanoparticle formulations carrying silver antimicrobials as aerosolized therapeutics. ACS Nano 7, 4977\u20134987 (2013).","journal-title":"ACS Nano"},{"key":"24200_CR31","doi-asserted-by":"publisher","first-page":"18467","DOI":"10.1021\/ja309037m","volume":"134","author":"S Zhang","year":"2012","unstructured":"Zhang, S. et al. Rapid and versatile construction of diverse and functional nanostructures derived from a polyphosphoester-based biomimetic block copolymer system. J Am Chem Soc 134, 18467\u201318474 (2012).","journal-title":"J Am Chem Soc"},{"key":"24200_CR32","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1021\/nn507046h","volume":"9","author":"YH Lim","year":"2015","unstructured":"Lim, Y. H. et al. Preparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide). ACS Nano 9, 1995\u20132008 (2015).","journal-title":"ACS Nano"},{"key":"24200_CR33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd3801","volume":"11","author":"PY Muller","year":"2012","unstructured":"Muller, P. Y. & Milton, M. N. The determination and interpretation of the therapeutic index in drug development. Nat Rev Drug Discov 11, 751\u2013761 (2012).","journal-title":"Nat Rev Drug Discov"},{"key":"24200_CR34","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1039\/c3md00082f","volume":"4","author":"TA Aweda","year":"2013","unstructured":"Aweda, T. A. et al. The use of 111Ag as a tool for studying biological distribution of silver-based antimicrobials. Med Chem Comm 4, 1015\u20131017 (2013).","journal-title":"Med Chem Comm"},{"key":"24200_CR35","doi-asserted-by":"crossref","unstructured":"Aweda, T. A. et al. Investigating the pharmacokinetics and biological distribution of silver-loaded polyphosphoester-based nanoparticles using 111Ag as a radiotracer. J Labelled Comp Radiopharm 58 (2015).","DOI":"10.1002\/jlcr.3289"},{"key":"24200_CR36","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1021\/jm070282e","volume":"50","author":"Q Xiao","year":"2007","unstructured":"Xiao, Q. & Pei, D. High-throughput synthesis and screening of cyclic peptide antibiotics. J Med Chem 50, 3132\u20133137 (2007).","journal-title":"J Med Chem"},{"key":"24200_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/psc.882","volume":"13","author":"WL Zhu","year":"2007","unstructured":"Zhu, W. L., Hahm, K. S. & Shin, S. Y. Cathelicidin-derived Trp\/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action. J Pept Sci 13, 529\u2013535 (2007).","journal-title":"J Pept Sci"},{"key":"24200_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/bip.10374","volume":"71","author":"DL Lee","year":"2003","unstructured":"Lee, D. L. & Hodges, R. S. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S. Biopolymers 71, 28\u201348 (2003).","journal-title":"Biopolymers"},{"key":"24200_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd3591","volume":"11","author":"CD Fjell","year":"2012","unstructured":"Fjell, C. D., Hiss, J. A., Hancock, R. E. & Schneider, G. Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 11, 37\u20135 (2012).","journal-title":"Nat Rev Drug Discov"},{"key":"24200_CR40","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.bbamem.2008.09.013","volume":"1788","author":"K Matsuzaki","year":"2009","unstructured":"Matsuzaki, K. Control of cell selectivity of antimicrobial peptides. Biochim Biophys Acta 1788, 1687\u20131692 (2009).","journal-title":"Biochim Biophys Acta"},{"key":"24200_CR41","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/toxsci\/kfu080","volume":"140","author":"IM Copple","year":"2014","unstructured":"Copple, I. M. et al. Chemical tuning enhances both potency toward nrf2 and in vitro therapeutic index of triterpenoids. Toxicol Sci 140, 462\u2013469 (2014).","journal-title":"Toxicol Sci"},{"key":"24200_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/00006534-199309000-00018","volume":"92","author":"ST Boyce","year":"1993","unstructured":"Boyce, S. T. & Holder, I. A. Selection of topical antimicrobial agents for cultured skin for burns by combined assessment of cellular cytotoxicity and antimicrobial activity. Plast Reconstr Surg 92, 493\u2013500 (1993).","journal-title":"Plast Reconstr Surg"},{"key":"24200_CR43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0009-2797(02)00003-0","volume":"139","author":"E Hidalgo","year":"2002","unstructured":"Hidalgo, E., Bartolome, R. & Dominguez, C. Cytotoxicity mechanisms of sodium hypochlorite in cultured human dermal fibroblasts and its bactericidal effectiveness. Chem Biol Interact 139, 265\u2013282 (2002).","journal-title":"Chem Biol Interact"},{"key":"24200_CR44","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00006534-198503000-00016","volume":"75","author":"W Lineaweaver","year":"1985","unstructured":"Lineaweaver, W., McMorris, S., Soucy, D. & Howard, R. Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg 75, 394\u2013396 (1985).","journal-title":"Plast Reconstr Surg"},{"key":"24200_CR45","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0305-4179(92)90180-3","volume":"18","author":"O Damour","year":"1992","unstructured":"Damour, O. et al. Cytotoxicity evaluation of antiseptics and antibiotics on cultured human fibroblasts and keratinocytes. Burns 18, 479\u2013485 (1992).","journal-title":"Burns"},{"key":"24200_CR46","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/jac\/dkn125","volume":"61","author":"G Muller","year":"2008","unstructured":"Muller, G. & Kramer, A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. J Antimicrob Chemother 61, 1281\u20131287 (2008).","journal-title":"J Antimicrob Chemother"},{"issue":"A","key":"24200_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/jac\/15.suppl_A.125","volume":"15","author":"J Blaser","year":"1985","unstructured":"Blaser, J. In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. J Antimicrob Chemother 15(A), 125\u2013130 (1985).","journal-title":"J Antimicrob Chemother"},{"key":"24200_CR48","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/AAC.41.6.1281","volume":"41","author":"AA Firsov","year":"1997","unstructured":"Firsov, A. A., Vostrov, S. N., Shevchenko, A. A. & Cornaglia, G. Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model. Antimicrob Agents Chemother 41, 1281\u20131287 (1997).","journal-title":"Antimicrob Agents Chemother"},{"key":"24200_CR49","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/AAC.42.11.2841","volume":"42","author":"AA Firsov","year":"1998","unstructured":"Firsov, A. A., Vostrov, S. N., Shevchenko, A. A., Portnoy, Y. A. & Zinner, S. H. A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve\/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities. Antimicrob Agents Chemother 42, 2841\u20132847 (1998).","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"24200_CR50","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1086\/321850","volume":"33","author":"A MacGowan","year":"2001","unstructured":"MacGowan, A., Rogers, C. & Bowker, K. In vitro models, in vivo models, and pharmacokinetics: what can we learn from in vitro models? Clin Infect Dis 33(3), S214\u2013220 (2001).","journal-title":"Clin Infect Dis"},{"key":"24200_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.taap.2009.11.023","volume":"243","author":"A Ibricevic","year":"2010","unstructured":"Ibricevic, A., Brody, S. L., Youngs, W. J. & Cannon, C. L. ATP7B detoxifies silver in ciliated airway epithelial cells. Toxicol Appl Pharmacol 243, 315\u2013322 (2010).","journal-title":"Toxicol Appl Pharmacol"},{"key":"24200_CR52","doi-asserted-by":"crossref","unstructured":"Bara, A. I. & Barley, E. A. Caffeine for asthma. Cochrane Database Syst Rev, CD001112 (2001).","DOI":"10.1002\/14651858.CD001112"},{"key":"24200_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/cc2955","volume":"8","author":"V Bewick","year":"2004","unstructured":"Bewick, V., Cheek, L. & Ball, J. Statistics review 12: survival analysis. Crit Care 8, 389\u2013394 (2004).","journal-title":"Crit Care"},{"key":"24200_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijpharm.2014.07.004","volume":"473","author":"HK Ruiz","year":"2014","unstructured":"Ruiz, H. K. et al. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp. Int J Pharm 473, 148\u2013157 (2014).","journal-title":"Int J Pharm"},{"key":"24200_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.25.1.10","volume":"25","author":"SL Spruance","year":"1984","unstructured":"Spruance, S. L., McKeough, M. B. & Cardinal, J. R. Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection. Antimicrob Agents Chemother 25, 10\u201315 (1984).","journal-title":"Antimicrob Agents Chemother"},{"key":"24200_CR56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/iai.48.1.57-61.1985","volume":"48","author":"EL Pesanti","year":"1985","unstructured":"Pesanti, E. L. & Nugent, K. M. Modulation of pulmonary clearance of bacteria by antioxidants. Infect Immun 48, 57\u201361 (1985).","journal-title":"Infect Immun"},{"key":"24200_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1165\/ajrcmb.10.1.7507342","volume":"10","author":"AL Cozens","year":"1994","unstructured":"Cozens, A. L. et al. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10, 38\u201347 (1994).","journal-title":"Am J Respir Cell Mol Biol"},{"key":"24200_CR58","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1378\/chest.123.1.28","volume":"123","author":"DE Geller","year":"2003","unstructured":"Geller, D. E., Rosenfeld, M., Waltz, D. A., Wilmott, R. W. & AeroDose, T. S. G. Efficiency of pulmonary administration of tobramycin solution for inhalation in cystic fibrosis using an improved drug delivery system. Chest 123, 28\u201336 (2003).","journal-title":"Chest"},{"key":"24200_CR59","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1086\/382962","volume":"189","author":"S Knapp","year":"2004","unstructured":"Knapp, S. et al. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia. J Infect Dis 189, 1506\u20131515 (2004).","journal-title":"J Infect Dis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24200-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24200-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24200-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:37:23Z","timestamp":1671597443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24200-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24200"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24200-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"8 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.J.Y., M.J.P. and C.L.C. share a patent for silver carbene complexes (SCCs) as antimicrobials. W.J.Y. and M.J.P. have a significant financial interest in the Akron Research Commercialization Corporation that is selling the SCCs described in this research. W.J.Y. and M.J.P. share a patent for encapsulating SCCs in polymeric nanoparticles for uses as chemotherapeutic agents. C.L.C. receives honoraria as a member of a Speaker\u2019s Bureau for Gilead Sciences, manufacturers of the aerosolized antimicrobial, Cayston<sup>\u00ae<\/sup>. K.L.W., S.Z. and F.Z. share a patent for the synthesis of the polymeric nanosystems described in this manuscript as delivery systems for chemotherapeutic agents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6376"}}